74 reports

  • OF CONTENTS

The readout of one of the most watched trials of Merck & Co. '

  • HIV AIDS
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group

You can easily book an appointment with one online.

  • HIV AIDS
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • HIV AIDS
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.

Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous System Disease - Diagnostic Tests - Vaccines and Drugs d.

  • Hepatitis
  • HIV AIDS
  • Infectious Disease
  • United States
  • World
  • ALERE: KEY TAKEAWAYS
  • MARKET SHARE ANALYSIS 2014

Alere' s POC products are available for infectious diseases such as respiratory syncytial virus (RSV), influenza, tuberculosis, pneumonia, HIV, AIDS, gastrointestinal disease, dengue, and malaria.

  • HIV AIDS
  • World
  • Alere Inc.
  • DiaSorin S.p.A.
  • Roche Group
  • Medestea Research & Production S.p.A. - Research and Development Overview
  • Key Therapeutic Areas

## or NR##C##) ## ## ## ## ## HIV ## p## ## ## ## ## ## Free Radical ## ## ## ## ## P##X Purinoceptor ## (P##Z Receptor or P##RX##) ## ## ## ## ## Prostaglandin G/ H Synthase ## (Cyclooxygenase ## or COX## or Prostaglandin Endoperoxide Sy

  • HIV AIDS
  • Therapy
  • World
  • Supply
  • Medestea

Eosinophils are pro-inflammatory cells that make a major contribution to allergic diseases affecting the upper and lower airways, skin and gastrointestinal tract.

  • HIV AIDS
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

GASTROINTESTINAL INCLUDES NEXIUM ##HR/ NEXIUM CONTROL.

  • HIV AIDS
  • Canada
  • North America
  • United States
  • Mylan Inc.
  • COMMON ROUTES OF VIRAL ENTRY

THESE CONDITIONS MAY BE ASSOCIATED WITH SYMPTOMS SUCH AS JAUNDICE, HEMATEMESIS, DARK-COLORED URINE OR FECES, EDEMA AND GASTROINTESTINAL SYMPTOMS (NHS, 2015C).

  • HIV AIDS
  • Therapy
  • World
  • Market Size
  • Gilead Sciences, Inc.

HIV

4546 5000 3864
  • Reyataz late-phase trial data in HIV-1 infection
  • Reyataz pivotal trial data in HIV-1 infection

Gastrointestinal (GI) toxicities were documented in a similar percentage of patients in the Tybost (##. ##%) and Norvir (##. ##%) treatment arms.

  • HIV AIDS
  • Europe
  • European Union
  • North America
  • United States
  • MARKET OVERVIEW

BY 2050, A GREATER SHARE ## U. S.

  • HIV AIDS
  • China
  • Abbott Laboratories, Inc.
  • Immucor, Inc.
  • Roche Group

All Regado shares will be subject to the nine for one reverse stock split.

  • HIV AIDS
  • United States
  • Company
  • Corporate Finance
  • Tobira Therapeutics, Inc.

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • HIV AIDS
  • Therapy
  • India
  • United States
  • Hetero Drugs Limited

This agreement enables IOCB to focus on the treatment of neurological diseases, cancer, and gastrointestinal disorders.

  • Healthcare
  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States

Christian Bréchot, one of the world' s most distinguished infectious diseases experts.

  • HIV AIDS
  • Pharmaceutical
  • France
  • Company
  • ABIVAX

This agreement enables IOCB to focus on the treatment of neurological diseases, cancer, and gastrointestinal disorders.

  • Healthcare
  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States

## Stroke ## Sudden Cardiac Arrest ## Superficial Femoral Artery Disease ## Thrombosis ## Traumatic Brain Injury ## Tremor ## Tumor ## Venous Disease ## Ventricular Arrhythmia ## Ventricular Fibrillation ## Ventr

  • Cardiac Management
  • Cardiovascular Disease
  • HIV AIDS
  • Magnetic Resonance Imaging
  • Boston Scientific Corporation

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Digestive System Disorder
  • HIV AIDS
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.

The current study of safety and activity of CYT## treatment in genotype ## and ## patients resistant to one or multiple lines of SOC focuses on one of the more difficult segments of the HCV patient population and strongly supports the potential of additional studies with th

  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Cytheris SA

OSUCCC provides clinical services in therapeutic areas of benign hematology, genitourinary, gastrointestinal, sarcoma and cancer genetics, among others.

  • HIV AIDS
  • Pharmaceutical
  • United States
  • Company
  • Bristol-Myers Squibb Company

OSUCCC provides clinical services in therapeutic areas of benign hematology, genitourinary, gastrointestinal, sarcoma and cancer genetics, among others.

  • HIV AIDS
  • Pharmaceutical
  • United States
  • Company
  • Bristol-Myers Squibb Company
  • PIPELINE BY OSEL, INC., H1 2016
  • PIPELINE BY NAVIGEN INC, H1 2018

The company' s products are used in the therapeutic areas of women' s health and gastrointestinal tract disorders, including recurrent urinary tract infections, recurrent bacterial vaginosis, inflammatory bowel diseases, and antibioticassociated diarrhea.

  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Mymetics Corporation

The prominent features of this report are - ##.

  • Clinical Trial
  • HIV AIDS
  • Pharmaceutical
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • HIV AIDS
  • Sexually Transmitted Disease
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • PIPELINE BY OSEL INC, H2 2017
  • PIPELINE BY PHARIS BIOTEC GMBH, H2 2017

The company' s products are used in the therapeutic areas of women' s health and gastrointestinal tract disorders, including recurrent urinary tract infections, recurrent bacterial vaginosis, inflammatory bowel diseases, and antibioticassociated diarrhea.

  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Mymetics Corporation

Results from the Phase I/ II study were presented at the 2017 Gastrointestinal Cancers Symposium.

  • Chemotherapy
  • HIV AIDS
  • Therapy
  • United States
  • Product Initiative

Boku Abstract ##O Proffered Paper Session: Gastrointestinal Tumors, Non-Colorectal ## Friday, September ##, ##:##-##:## PM CEST, Barcelona Auditorium Author: Y.

  • HIV AIDS
  • Lung Cancer
  • Pharmaceutical
  • United States
  • Ono Pharmaceutical Co., Ltd.

One study recruits children as young as one year old with a particularly aggressive form of neuroblastoma.

  • Cancer
  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States

Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous System Disease - Diagnostic Tests - Vaccines and Drugs d.

  • Hepatitis
  • HIV AIDS
  • Infectious Disease
  • United States
  • World

One unit refers to one standard ablation catheter.

  • Catheter
  • Clinical Trial
  • Drug Discovery And Development
  • HIV AIDS
  • Boston Scientific Corporation